Skip navigation

Yaqrit Ltd

Yaqrit is developing treatments for liver disease. Twenty years of work in liver disease has led to a family of breakthroughs, now combined with experienced management to bring new treatments to liver patients around the world.

Our first programmes are for severely ill patients - with cirrhosis or Acute-on-Chronic Liver Failure (ACLF). We plan to broaden our approach to include patients with complication of cirrhosis, Non-Alcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD), which affects more than 25% of populations in developed economies*.